Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Acta Oto-Laryngologica

Volumn 127, Issue 10, 2007, Pages 1099-1104

  Katori, Hideaki ^a,b   Tsukuda, Mamoru ^c   Taguchi, Takahide ^c  

^a YOKOHAMA CITY MINATO RED CROSS HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Carboplatin; Chemoradiotherapy; Performance status; Squamous cell carcinoma of the head and neck (SCCHN); Uracil f tegafur (UFT)

Indexed keywords

CARBOPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; UFT;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DISTRIBUTION; FEMALE; FUNCTIONAL STATUS; GLOMERULUS FILTRATION RATE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; XEROSTOMIA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 34648821976     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701200251     Document Type: Article

References (25)

1. Million RR, Cassisi NJ. Management of head and neck cancer. In: Cripps C, editor. A multidisciplinary approach. Philadelphia, PA: JB Lippincott; 1994. p. 124-8.
2. World Health Organization. Handbook for reporting results of cancer treatment. In: World Health Organization, ed. WHO offset publication no. 48. Geneva: WHO, 1979:189-96.
3. Havelik RJ, Yancik R, Long S. The National Cancer Institute on aging and the National Cancer Institute SEER. Collaborative studies on comorbidities and early diagnosis of cancer in the elderly. Cancer 1994;74(Suppl):2101-6.
4. Monfardini S. What do we know about the variables influencing clinical decision-making in elderly cancer patients? Eur J Cancer 1996;32:12-4.
5. Johnson EDH, Zhv J, Schiller J. ECOG 1594: a randomized phase III trial in metastatic non-small cell lung cancer (NSCLC). Outcome of PS 2 patients: an Eastern Cooperative Oncology Group Trial. Proc Am Soc Clin Oncol 1999;18:416a (abstract).
6. Katori H, Nozawa A, Tsukuda M. Post-operative adjuvant chemoradiotherapy with carboplatin and 5-fluorouracil for primary branchiogenic carcinoma. J Laryngol Otol 2005;119:467-9.
7. Taguchi T, Ikeda Y, Mikami Y. Combination radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma. Anticancer Res 2003;23:713-8.
8. Taguchi T, Katori H, Tsukuda M. Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur in patients with stage two (T 2 N 0 M 0) squamous cell carcinoma of the glottic larynx. J Laryngol Otol 2006;120:478-81.
9. Eisenberger M, Hornedo J. Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous cell carcinoma of head and neck. J Clin Oncol 1986;4:1506-9.
10. Harland SJ, Newell DR, Siddik ZH. 2Pharmacokinetics of cis-diammine-1, 1-cyclobutane dicarboxylate platinum (II) in patients with normal and impaired renal function. Cancer Res 1984;44:1693-7.
11. Minsky BD. UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review. Int J Cancer 2001;96:1-10.
12. Calvert AH, Newell DR, Gumbrell LA. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989;7:1748-56.
13. Katori H, Tsukuda M, Mochimatu I. 2Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Br J Cancer 2004;90:348-52.
14. Katori H, Tsukuda M, Ishitoya J. Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Proc Am Soc Clin Oncol 2004;23:14S (abstract 5560).
15. Katori H, Tsukuda M. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck. Clin Oncol 2005;17:148-52.
16. Kish J, Ensley J, Jacobs J. A randomized trial of cisplatin (CACP)+5-fluorouracil (5-FU) infusion and CACP+5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 1985;56:2740-4.
17. Al-Sarraf M, Pajak TF, Marcial VA. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck: an RTOG study. Cancer 1987;59:259-65.
18. Tobias JS, Smith BJ, Blackman G. Concurrent daily cisplatin and radiotherapy in locally advanced squamous carcinoma of the head and neck and bronchus. Radiother Oncol 1987;9:263-8.
19. Browman GP, Cripps C, Hodson DI. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 1994;12:2648-53.
20. Koukourakis M, Bizakis J, Skoulakis C. Combined irinotecan, docetaxel and conventionally fractionated radiotherapy in locally advanced head and neck cancer. A phase I dose escalation study. Anticancer Res 1999;19:2305-9.
21. Calais G, Alfonsi M, Bardet E. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-6.
22. Dimery I, Hong W. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85:95-111.
23. Lefebvre J, Chevalier D, Luboinski B. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996;88:890-8.
24. Merlano M, Benasso M, Corvo R. Five year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996;88:583-9.
25. Taylor S IV, Murthy A, Vannetzel J. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994;12:385-95.